This tool supports structured infectious-disease decision making but does not replace clinician judgement or local guideline pathways.
This OpiCalc infectious-disease entry reflects commonly used guideline criteria and bedside risk features used in contemporary clinical practice.
Vancomycin AUC Dosing: Target-based vancomycin monitoring emphasizing an AUC/MIC goal of 400-600.
Serious MRSA infection
+2 Points
Rapidly changing renal function
Obesity or unusual Vd
+1 Points
MIC >1 concern
Concurrent nephrotoxins
Trough-only monitoring currently used
Assessment Tier
Score 0
No major complexity flag selected.